Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA-binding protein PNO1 is a highly conserved RNA-binding protein involved in the biogenesis of the small ribosomal subunit in eukaryotes. As a component of the small subunit (SSU) processome, PNO1 facilitates critical steps in ribosome assembly, including rRNA folding, modification, and cleavage, and positively regulates dimethylation of adenosines in the 18S rRNA. Beyond its basic cellular function, PNO1 is upregulated in multiple cancers where it promotes tumor cell proliferation, cell cycle progression, migration, invasion, and survival by engaging in several oncogenic signaling pathways (such as MAPK, TGF-β, and Notch), inhibiting ferroptosis, and regulating autophagy and metabolic reprogramming. Its suppression can reactivate tumor-suppressive pathways like p53. PNO1 is essential for global protein synthesis and is localized primarily in the nucleolus and nucleoplasm[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA-binding protein PNO1 (PNO1).